UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Clinical Significance of Long Intergenic Noncoding RNA-p21 in Colorectal Cancer

Clinical colorectal cancer, 2013-12, Vol.12 (4), p.261-266

2013

Link zum Volltext

Verfügbarkeit prüfen

microRNA based prognostic biomarkers in pancreatic Cancer

Biomarker research, 2018-05, Vol.6 (1), p.18-18, Article 18

2018

Link zum Volltext

Verfügbarkeit prüfen

Development of novel 5-FU modified siRNA against BCL-2 with enhanced efficacy and vehicle-free cellular uptake

Genes & diseases, 2024-01, Vol.11 (1), p.23-25

2024

Link zum Volltext

Verfügbarkeit prüfen

Correction: Soung et al. Therapeutic Potential of Chemically Modified MiR-489 in Triple-Negative Breast Cancers. Cancers 2020, 12 , 2209

Cancers, 2024-02, Vol.16 (5), p.1010

2024

Link zum Volltext

Verfügbarkeit prüfen

Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer

Molecular therapy. Oncolytics, 2023-03, Vol.28, p.277-292

2023

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers

Cancers, 2020-08, Vol.12 (8), p.2209

2020

Link zum Volltext

Verfügbarkeit prüfen

The expanding regulatory universe of p53 in gastrointestinal cancer

F1000 research, 2016, Vol.5, p.756-756

2016

Link zum Volltext

Verfügbarkeit prüfen

Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1

Oncotarget, 2018-01, Vol.9 (2), p.2367-2383

2018

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy

Oncotarget, 2015-08, Vol.6 (23), p.19735-19746

2015

Link zum Volltext

Verfügbarkeit prüfen

Development of microRNA-based therapy for pancreatic cancer

Journal of pancreatology (Online), 2019-12, Vol.2 (4), p.147-151

2019

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA: A third dimension in autophagy

Cell cycle (Georgetown, Tex.), 2013-01, Vol.12 (2), p.246-250

2013

Link zum Volltext

Verfügbarkeit prüfen

Autophagy regulated by miRNAs in colorectal cancer progression and resistance

Cancer translational medicine, 2017-01, Vol.3 (3), p.96-100

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4063: Design and development of a novel 5-FU modified siRNA against BCL2 with enhanced efficacy and the unique ability to be delivered vehicle free into cancer cells

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4063-4063

2020

Link zum Volltext

Verfügbarkeit prüfen

Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cells

Oncotarget, 2018-02, Vol.9 (10), p.8887-8897

2018

Link zum Volltext

Verfügbarkeit prüfen

Expression analysis of microRNA as prognostic biomarkers in colorectal cancer

Oncotarget, 2017-08, Vol.8 (32), p.52403-52412

2017

Link zum Volltext

Verfügbarkeit prüfen

Overcoming chemoresistance in cancer stem cells with the help of microRNAs in colorectal cancer

Epigenomics, 2017-06, Vol.9 (6), p.793-796

2017

Link zum Volltext

Verfügbarkeit prüfen

Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics

Molecular therapy, 2022-11, Vol.30 (11), p.3450-3461

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3117: Hsa-miR-140-5p inhibits colorectal cancer stem cell invasion and metastasis by suppressing Smad2 and autophagy

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3117-3117

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3079: Mechanism of hsa-miR-15a in EMT and chemoresistance in colorectal cancer

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3079-3079

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2141: Development of a novel miR-129 mimic with enhanced therapeutic potential for treatment of resistant colorectal cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2141-2141

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5443: Developing a novel miR-15a mimic as a potential therapeutic molecule to eliminate resistant colorectal cancer stem cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5443-5443

2017

Link zum Volltext

Verfügbarkeit prüfen

Correction: Soung et al. Therapeutic Potential of Chemically Modified MiR-489 in Triple-Negative Breast Cancers. ICancers/I 2020, I12/I, 2209

Cancers, 2024-02, Vol.16 (5)

2024

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4403: Development of 5-FU modified tumor suppressor miRNAs as a platform for miRNA based cancer therapeutics

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4403-4403

2018

Link zum Volltext

Verfügbarkeit prüfen

Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma

Molecular therapy. Nucleic acids, 2020-03, Vol.19, p.228-239

2020

Link zum Volltext

Verfügbarkeit prüfen

Circulating microRNA Testing for the Early Diagnosis and Follow-up of Colorectal Cancer Patients

Molecular diagnosis & therapy, 2014-06, Vol.18 (3), p.303-308

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Englisch
(41)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(11)
Oncotarget
(6)
Cancers
(3)
Biology Of Blood And Marrow Transplantation
(2)
Cancer Translational Medicine
(2)
Biomarker Research
(1)
Blood
(1)
Cell Cycle
(1)
Clinical Colorectal Cancer
(1)
Epigenomics
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical Significance of Long Intergenic Noncoding RNA-p21 in Colorectal Cancer

microRNA based prognostic biomarkers in pancreatic Cancer

Development of novel 5-FU modified siRNA against BCL-2 with enhanced efficacy and vehicle-free cellular uptake

Correction: Soung et al. Therapeutic Potential of Chemically Modified MiR-489 in Triple-Negative Breast Cancers. Cancers 2020, 12 , 2209

Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer

Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers

The expanding regulatory universe of p53 in gastrointestinal cancer

Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1

Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy

Development of microRNA-based therapy for pancreatic cancer

MicroRNA: A third dimension in autophagy

Autophagy regulated by miRNAs in colorectal cancer progression and resistance

Abstract 4063: Design and development of a novel 5-FU modified siRNA against BCL2 with enhanced efficacy and the unique ability to be delivered vehicle free into cancer cells

Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cells

Expression analysis of microRNA as prognostic biomarkers in colorectal cancer

Overcoming chemoresistance in cancer stem cells with the help of microRNAs in colorectal cancer

Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics

Abstract 3117: Hsa-miR-140-5p inhibits colorectal cancer stem cell invasion and metastasis by suppressing Smad2 and autophagy

Abstract 3079: Mechanism of hsa-miR-15a in EMT and chemoresistance in colorectal cancer

Abstract 2141: Development of a novel miR-129 mimic with enhanced therapeutic potential for treatment of resistant colorectal cancer

Abstract 5443: Developing a novel miR-15a mimic as a potential therapeutic molecule to eliminate resistant colorectal cancer stem cells

Correction: Soung et al. Therapeutic Potential of Chemically Modified MiR-489 in Triple-Negative Breast Cancers. ICancers/I 2020, I12/I, 2209

Abstract 4403: Development of 5-FU modified tumor suppressor miRNAs as a platform for miRNA based cancer therapeutics

Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma

Circulating microRNA Testing for the Early Diagnosis and Follow-up of Colorectal Cancer Patients

Suchergebnisse filtern